Akumin, a leader in managed radiology and oncology services, is pleased to announce the appointment of Dr. Nasir Siddiqui as Chief Medical Officer (CMO).
As Chief Medical Officer, Dr. Siddiqui will lead Akumin’s clinical strategic priorities with a focus on quality and safety, operational excellence and efficiency, integration of technology to enhance productivity and clinical accuracy, and innovative care delivery.
Health Technology Insights: Cantata Health Solutions Launches Medication-Assisted Treatment Module in Arize EHR
“Joining Akumin as Chief Medical Officer is both an honor and a responsibility,” said Dr. Siddiqui. “As a national leader in medical imaging and oncology services, Akumin is uniquely positioned to tackle pressing healthcare challenges by enhancing service delivery and driving innovation across its highly differentiated platform. With this nationwide imaging-and-oncology network, we can raise the bar for quality, precision, and equitable access in patient care. My priority is to translate clinical insight into operational excellence, so every patient, physician, and partner experiences the very best Akumin has to offer.”
Health Technology Insights: Creative Solutions in Healthcare Names Chelsea Jordan VP
Dr. Siddiqui brings a unique blend of clinical expertise and operational insight to this role. He received his Doctor of Medicine (MD) from Case Western Reserve University and completed his residency in Radiology at the University of Pittsburgh Medical Center. In addition, he holds a Master of Business Administration (MBA) from the University of Chicago Booth School of Business. Prior to joining Akumin, Dr. Siddiqui served as Chair of Radiology at Duly Health and Care, a large multispecialty practice in the Chicago area.
“We are delighted to welcome Dr. Siddiqui to Akumin,” said Henry Howe, Akumin CEO. “His distinguished track record of clinical excellence, operational expertise, and strategic leadership will be instrumental as we continue to advance our mission of delivering high-quality, patient-centered care.”
Health Technology Insights: Why FDA-Approved AI Innovations Are the Future of Healthcare in 2025
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
